Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Ottawa
$27,000.00
Evaluating the translational relevance of pre-clinical models of cancer cachexia
FY 2025-26
Summary
Background
Cancer cachexia (CC) is a serious condition in which people with cancer lose muscle, experience inflammation, and develop metabolic problems. It greatly reduces strength, quality of life, and survival. Although researchers commonly study CC using cancer cells and mouse models, it is not clear how well these models actually reflect what happens in people. My project will test how accurately these models reproduce the muscle wasting and biological changes seen in human CC.
Methods
Aim 1 will examine the cachectic effects of several types of mouse cancers, specifically colon cancer, melanoma, and brain cancer, using both muscle cell cultures and tumour-bearing mice. In cell culture studies, I will treat mouse muscle cells with substances released by these cancers to see whether they impair muscle growth or cause muscle fibres to shrink. In mice, I will track changes in body weight, fat, and muscle over time and examine the muscles and organs after tumours develop. These experiments will follow procedures previously optimized in our lab’s lung cancer model, allowing direct comparison across cancer types.
Aim 2 will test whether human cancers such as glioblastoma, lung cancer, ovarian cancer, and colorectal cancer produce similar muscle-wasting effects. I will treat human muscle cells with substances released by these cancers to determine whether they cause muscle atrophy or disrupt normal muscle formation.
Significance
By comparing results across mouse and human systems, this research will reveal which cancers and experimental models reliably cause cachexia. This will help create more accurate and standardized tools for studying CC and ultimately improve the development of future treatments.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
576682
Name
Brant Tessa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the translational relevance of pre-clinical models of cancer cachexia
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Cachexia; Muscle Wasting; Myoblast Differentiation; Preclinical Models; Translational Research
Abstract
Background
Cancer cachexia (CC) is a serious condition in which people with cancer lose muscle, experience inflammation, and develop metabolic problems. It greatly reduces strength, quality of life, and survival. Although researchers commonly study CC using cancer cells and mouse models, it is not clear how well these models actually reflect what happens in people. My project will test how accurately these models reproduce the muscle wasting and biological changes seen in human CC.
Methods
Aim 1 will examine the cachectic effects of several types of mouse cancers, specifically colon cancer, melanoma, and brain cancer, using both muscle cell cultures and tumour-bearing mice. In cell culture studies, I will treat mouse muscle cells with substances released by these cancers to see whether they impair muscle growth or cause muscle fibres to shrink. In mice, I will track changes in body weight, fat, and muscle over time and examine the muscles and organs after tumours develop. These experiments will follow procedures previously optimized in our lab’s lung cancer model, allowing direct comparison across cancer types.
Aim 2 will test whether human cancers such as glioblastoma, lung cancer, ovarian cancer, and colorectal cancer produce similar muscle-wasting effects. I will treat human muscle cells with substances released by these cancers to determine whether they cause muscle atrophy or disrupt normal muscle formation.
Significance
By comparing results across mouse and human systems, this research will reveal which cancers and experimental models reliably cause cachexia. This will help create more accurate and standardized tools for studying CC and ultimately improve the development of future treatments.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brant, Tessa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~